Jacobs Levy Equity Management, Inc Beyond Spring Inc. Transaction History

Jacobs Levy Equity Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$9.26 - $31.31 $1.16 Million - $3.91 Million	-124,808 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.37 - $12.12 $191,981 - $248,326	20,489 Added 19.64%	124,808 $1.3 Million
Q1 2021 May 17, 2021	BUY	$10.61 - $15.77 $199,818 - $296,996	18,833 Added 22.03%	104,319 $1.16 Million
Q4 2020 Feb 16, 2021	SELL	$10.21 - $17.31 $32,437 - $54,993	-3,177 Reduced 3.58%	85,486 $1.04 Million
Q3 2020 Nov 16, 2020	BUY	$9.99 - $16.13 $271,398 - $438,203	27,167 Added 44.18%	88,663 $1.18 Million

Q2 2020 Aug 17, 2020	BUY	$11.21 - $18.15 $3,172 - $5,136	283 Added 0.46%	61,496 $927,000
Q1 2020 May 15, 2020	BUY	$9.68 - $18.47 $21,557 - $41,132	2,227 Added 3.78%	61,213 $784,000
Q4 2019 Feb 14, 2020	BUY	$11.83 - $18.68 $697,804 - $1.1 Million	58,986 New	58,986 $914,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.